Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neurotoxicity Syndromes 1HR Positive HER2 Negative Advanced Breast Cancer 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1

Interventions

eribulin 1camrelizumab 1bismuth tripotassium dicitrate 1Pregabalin 1Ofloxacin 1Metronidazole 1Levofloxacin 1Esomeprazole 1Clarithromycin 1Amoxicillin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Drug-Related Side Effects and Adverse Reactions × eribulin × Clear all
NCT02864030 2021-03-04

PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment

Oncologia Medica dell'Ospedale Fatebenefratelli

Phase 4 Completed
200 enrolled
Breast

Breast Neoplasms, Neurotoxicity Syndromes, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡